🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s ALVO Holdings & Trades

First Buy
Q1 2024
Duration Held
3 Quarters
Largest Add
Q4 2025
+14,840 Shares
Current Position
14,840 Shares
$76,129 Value

Steven Cohen's ALVO Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 14,840 shares of Alvotech (ALVO) worth $76,129, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 3 quarters.

Based on 13F filings, Steven Cohen has maintained this position in ALVO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 14,840 shares. Largest reduction occurred in Q2 2024, reducing 11,700 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Alvotech (ALVO) Holding Value Over Time

Track share changes against reported price movement

Quarterly Alvotech (ALVO) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +14,840 New Buy 14,840 $5.13
Q2 2024 -11,700 Sold Out 0 $0.00
Q1 2024 +11,700 New Buy 11,700 $12.22

Steven Cohen's Alvotech Investment FAQs

Steven Cohen first purchased Alvotech (ALVO) in Q1 2024, acquiring 11,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Alvotech (ALVO) for 3 quarters since Q1 2024.

Steven Cohen's largest addition to Alvotech (ALVO) was in Q4 2025, adding 14,840 shares worth $76,129.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 14,840 shares of Alvotech (ALVO), valued at approximately $76,129.

As of the Q4 2025 filing, Alvotech (ALVO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Alvotech (ALVO) was 14,840 shares, as reported at the end of Q4 2025.